TP63 isoform expression is linked with distinct clinical outcomes in cancer

BACKGROUND: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder cancer, but reports associating it with clinical outcomes are conflicting. Since TP63 is exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bankhead, Armand, McMaster, Thomas, Wang, Yin, Boonstra, Philip S., Palmbos, Phillip L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953644/
https://www.ncbi.nlm.nih.gov/pubmed/31927310
http://dx.doi.org/10.1016/j.ebiom.2019.11.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953644/
https://www.ncbi.nlm.nih.gov/pubmed/31927310
http://dx.doi.org/10.1016/j.ebiom.2019.11.022

Ejemplares similares